Skip to main content

Entigen Hires Former Incyte VP as New CEO

NEW YORK, June 28 - Entigen has hired Denise Gilbert, a former executive at Incyte and Affymax, as the company's new CEO, Entigen announced Thursday.

As CEO, Gilbert will work on marketing Entigen's technology platform and expanding the business beyond its traditional focus on bioinformatics. The company has yet to disclose specifics on its new direction.

Gilbert joins Entigen after serving as executive vice president and chief financial officer at Incyte. Prior to that, she served as vice president and chief financial officer at Affymax, (the company that spawned Affymetrix) where she participated in the company's 1995 acquisition by Glaxo Wellcome.

Prior to her six years as an executive in genomics companies, Gilbert, a PhD-trained biologist, spent seven years as a biotechnology analyst on Wall Street.

"Denise understands the technical challenges researchers must overcome to make productive use of abundant but geographically dispersed, heterogeneous life science data, can articulate the role of Entigen as a commercial solutions provider, and has the internal and external corporate management experience needed to execute our corporate strategy," Entigen chairman Bala Manian said in a statement.

Entigen, based in Sunnyvale, Calif., was formed in December 2000 from the merger of eBioinformatics, a provider of online software tools for life science data analysis, and Empatheon, which developed ADAAPT (Advanced Dynamic Access, Analysis, and Personalization Technology), a Java-based technology for accessing multiple types of biological data. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.